Invuity Announces Two Leadership Appointments

SAN FRANCISCO, December 9, 2014 – Invuity, Inc., a surgical photonics company, today announced two leadership appointments that further strengthen the company’s management team and plans for growth in the minimally invasive surgery market.

  • Paul O. Davison has been appointed vice president of research and development. He will be responsible for leading, directing and planning Invuity’s overall strategy for expanding the company’s portfolio of intelligent photonics™ intra-cavity visualization devices.
  • Doug Heigel has been appointed vice president of operations. He will be responsible for maximizing the company’s growth and profitability while leading and managing all operations functions.

“Paul and Doug have deep experiences and knowledge within the industry and will help to advance our company as we significantly scale the business to support growing demand,” said Invuity Chief Executive Officer Philip Sawyer. “Their leadership will be key as Invuity continues to lead in the development of intelligent photonics™ technology for advanced surgical visualization”

Davison has been involved in the development and commercialization of more than 25 medical devices. Most recently, as vice president and general manager at ConMed, he was responsible for the construction, opening and management of the development facility for the Edge™ system in San Mateo, CA. Prior to ConMed, Davison served as the vice president of research and development of PEAK Surgical, and helped lead the company to a $120 million acquisition by Medtronic in 2011. Davison is also an inventor on 12 issued U.S. patents assigned to Baxter, Medtronic, ArthroCare and PEAK Surgical – five of which are for medical devices currently on the market.

Heigel joins Invuity with over 25 years of operations management experience at medical device and technology companies, including Solta Medical (formerly Thermage, Inc.), Argonaut Technologies, and Biomolecular Technologies. At these companies, he established and managed commercial operations infrastructure and business processes for several business functions, including sales and operations planning, supply chain, manufacturing engineering and product development. At Solta Medical, Heigel led global operations, scaling capital equipment and consumable device operations from inception to $160 million in annual sales. He also led the company through a successful IPO, multiple acquisitions and the eventual sale to Valeant Pharmaceuticals.

About Invuity®

Invuity, Inc. is a surgical photonics company that develops and markets Intelligent Photonics™ devices. The company’s portfolio of intra-cavity visualization devices make possible new minimally invasive surgical approaches and techniques that result in increased surgical precision, efficiency and safety with improved patient outcomes. Clinical applications include breast and thyroid oncology, plastics, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.

MEDIA CONTACT:
Ashley Paula
Waggener Edstrom
apaula@waggeneredstrom.com
415-547-7024

INVESTOR CONTACT:
Matt Clawson
Life Capital Partners, LLC
949-370-8500

-####-